CNS mediated inhibition of gastric secretion by bombesin: independence from interaction with brain catecholaminergic, and serotoninergic pathways and pituitary hormones.
D015115:5,6-Dihydroxytryptamine / Q000494:pharmacology; D000818:Animals; D001839:Bombesin / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects / Q000502:physiology*; D002395:Catecholamines / Q000502:physiology*; D010134:Fenclonine / Q000494:pharmacology; D005744:Gastric Acid / Q000378:metabolism*; D006220:Haloperidol / Q000494:pharmacology; D006892:Hydroxydopamines / Q000494:pharmacology; D007016:Hypophysectomy; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D016627:Oxidopamine; D010455:Peptides / Q000494:pharmacology*; D011388:Prolactin / Q000097:blood; D051381:Rats; D011919:Rats, Inbred Strains; D012701:Serotonin / Q000502:physiology*; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors; D019805:alpha-Methyltyrosine
D002395:Catecholamines; D006892:Hydroxydopamines; D008781:Methyltyrosines; D010455:Peptides; D012701:Serotonin; D019805:alpha-Methyltyrosine; D016627:Oxidopamine; D011388:Prolactin; D014446:Tyrosine 3-Monooxygenase; D006220:Haloperidol; D001839:Bombesin; D010134:Fenclonine; D015115:5,6-Dihydroxytryptamine